Have a feature idea you'd love to see implemented?
Let us know!
ACET Adicet Bio Inc
Price (delayed)
$0.9
Market cap
$74.16M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.7
Enterprise value
-$13.12M
Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of 'off-the-shelf' gamma delta
Highlights
ACET's EPS is up by 49% year-on-year and by 33% since the previous quarter
The company's net income rose by 18% YoY and by 14% QoQ
The quick ratio has decreased by 17% from the previous quarter but it has increased by 12% YoY
Adicet Bio's equity has decreased by 10% QoQ but it has increased by 9% YoY
Key stats
What are the main financial stats of ACET
Market
Valuations
Earnings
Shares outstanding
82.4M
Market cap
$74.16M
Enterprise value
-$13.12M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.35
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$117.88M
EBITDA
-$108.21M
Free cash flow
-$92.84M
Per share
Balance sheet
Liquidity
EPS
-$1.7
Free cash flow per share
-$1.02
Book value per share
$2.57
Revenue per share
$0
TBVPS
$2.71
Total assets
$245.96M
Total liabilities
$34.43M
Debt
$18.2M
Equity
$211.53M
Working capital
$186.92M
Debt to equity
0.09
Current ratio
10.64
Quick ratio
10.42
Net debt/EBITDA
0.81
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-46.4%
Return on equity
-53.9%
Return on invested capital
-166.9%
Return on capital employed
-52%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ACET stock price
How has the Adicet Bio stock price performed over time
Intraday
-1.53%
1 week
-4.95%
1 month
-40.79%
1 year
-21.74%
YTD
-52.38%
QTD
-37.5%
Financial performance
How have Adicet Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$128.44M
Net income
-$117.88M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 18% YoY and by 14% QoQ
ACET's operating income is up by 16% YoY and by 13% from the previous quarter
Growth
What is Adicet Bio's growth rate over time
Valuation
What is Adicet Bio stock price valuation
P/E
N/A
P/B
0.35
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ACET's EPS is up by 49% year-on-year and by 33% since the previous quarter
ACET's price to book (P/B) is 71% lower than its 5-year quarterly average of 1.2 and 42% lower than its last 4 quarters average of 0.6
Adicet Bio's equity has decreased by 10% QoQ but it has increased by 9% YoY
Efficiency
How efficient is Adicet Bio business performance
Adicet Bio's ROIC has increased by 41% from the previous quarter and by 35% YoY
ACET's ROE is up by 16% QoQ and by 7% YoY
Adicet Bio's return on assets has increased by 15% QoQ and by 7% YoY
Dividends
What is ACET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ACET.
Financial health
How did Adicet Bio financials performed over time
The quick ratio has decreased by 17% from the previous quarter but it has increased by 12% YoY
ACET's current ratio is down by 17% since the previous quarter but it is up by 13% year-on-year
Adicet Bio's debt is 91% lower than its equity
ACET's debt to equity is down by 18% YoY but it is up by 13% QoQ
Adicet Bio's debt has decreased by 17% YoY and by 4.9% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.